← ANALYSTS · TIPRANKS
Etzer Darout · Barclays
Hits
63%
276 of 440 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+31.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
27
Buy / hold / sell: 23 / 3 / 1
Upside of the analyst’s targets
+113.1%
Average over 27 current targets, to the last price
The market’s answer to the ratings
+1.2%
Day-0 move against SPY in the rating’s direction, average over 12 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks 04:50 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $180 | +39.8% | −4.4%next day −0.5% | ↗ |
| Oct 13on TipRanks 04:50 | INCYSPYIncyte · $23.0B | Reiterated | Buy | $139 | +22.9% | −2.4%next day +3.8% | ↗ |
| Oct 13on TipRanks 04:50 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $271 | +28.9% | −2.9%next day +0.7% | ↗ |
| Oct 13on TipRanks 04:50 | IOVAIWMIovance Biotherapeutics · $6.7B | Reiterated | Buy | $15.00 → $18.00+20.0% | +32.2% | −0.4%next day −0.9% | ↗ |
| Oct 13on TipRanks 04:50 | LEGNLegend Biotech · $3.5B | Reiterated | Buy | $74.00 → $68.00−8.1% | +268.0% | +0.5%next day +7.6% | ↗ |
| Oct 13on TipRanks 04:50 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | $37.00 | +186.8% | −15.7%next day −1.9% | ↗ |
| Oct 13on TipRanks 04:50 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $65.00 | +88.6% | −6.9%next day +8.8% | ↗ |
| Oct 9on TipRanks 05:15 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $65.00 | +88.6% | −1.1%next day +7.0% · 5 days +10.2% | ↗ |
| Oct 9on TipRanks 04:50 | SRRKIWMScholar Rock Holding · $4.9B | Reiterated | Hold | $58.00 | +45.4% | −0.6%next day −0.5% · 5 days −3.5% | ↗ |
| Oct 8on TipRanks 05:25 | VIRIWMVir Biotechnology · $1.8B | Reiterated | Buy | $30.00 | +201.2% | −3.0%next day +4.6% · 5 days −5.6% | ↗ |
| Oct 7on TipRanks 03:55 | ELVNIWMEnliven Therapeutics · $2.9B | Reiterated | Buy | $78.00 | +109.0% | −2.2%next day −1.3% · 5 days −4.0% | ↗ |
| Oct 1on TipRanks 05:15 | SMMTSummit Therapeutics · $12.4B | Reiterated | Hold | $18.00 → $20.00+11.1% | +36.7% | −1.5%next day −0.4% · 5 days +1.6% | ↗ |
| Sep 29on TipRanks Sep 30 05:25 | IOVAIWMIovance Biotherapeutics · $6.7B | Reiterated | Buy | $15.00 | +10.1% | +31.7%next day +2.8% · 5 days −12.3% | ↗ |
| Sep 22on TipRanks Sep 23 05:05 | ANABIWMAnaptysBio · $1.5B | Reiterated | Buy | $75.00 | +60.9% | −1.8%next day −5.1% · 5 days −5.4% | ↗ |
| Sep 22on TipRanks Sep 23 05:05 | CLDXIWMCelldex · $2.3B | Reiterated | Buy | $53.00 | +92.5% | −11.5%next day −6.4% · 5 days −4.4% | ↗ |
| Sep 22on TipRanks 03:35 | ABVXAbivax SA Sponsored ADR · $8.6B | Reiterated | Buy | $148 | +67.9% | −5.0%next day −3.5% · 5 days +1.4% | ↗ |
| Sep 21on TipRanks 04:15 | ORKAIWMOruka Therapeutics · $4.9B | Reiterated | Buy | $160 | +122.4% | −3.2%next day +1.3% · 5 days −8.8% | ↗ |
| Sep 14on TipRanks 18:35 | SRRKIWMScholar Rock Holding · $4.9B | Downgrade | Hold | $55.00 → $58.00+5.5% | +45.4% | −3.1%next day −0.8% · 5 days 0.0% | ↗ |
| Sep 11on TipRanks 05:15 | XNCRIWMXencor · $1.8B | Reiterated | Buy | $27.00 → $35.00+29.6% | +53.2% | −0.2%next day +0.9% · 5 days +1.4% | ↗ |
| Sep 11on TipRanks 05:15 | LEGNLegend Biotech · $3.5B | Reiterated | Buy | $78.00 → $74.00−5.1% | +300.4% | −3.7%next day −0.1% · 5 days −5.4% | ↗ |
| Sep 11on TipRanks 05:15 | MNPRIWMMonopar Therapeutics Inc · $482M | Reiterated | Buy | $128 → $145+13.3% | +109.3% | −0.6%next day −1.3% · 5 days −12.4% | ↗ |
| Sep 10on TipRanks 05:37 | KURAIWMKura Oncology · $863M | Reiterated | Buy | $28.00 | +208.4% | −3.7%next day −2.4% · 5 days +0.7% | ↗ |
| Sep 10on TipRanks 05:31 | JAZZJazz Pharmaceuticals · $13.9B | Reiterated | Buy | $270 → $271+0.4% | +28.9% | +0.3%next day +1.4% · 5 days +0.8% | ↗ |
| Sep 10on TipRanks 05:31 | ONCBeOne Medicines · $40.3B | Reiterated | Buy | $407 → $415+2.0% | +12.4% | −2.0%next day +0.5% · 5 days +2.8% | ↗ |
| Sep 3on TipRanks 04:35 | TRAXIWMFirst Tracks Biotherapeutics Inc · $1.3B | Reiterated | Buy | $65.00 | +88.6% | −7.2%next day −4.4% · 5 days −13.1% | ↗ |
| Aug 31on TipRanks Sep 1 03:50 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $153 → $180+17.6% | +39.8% | +2.7%next day −0.2% · 5 days −1.1% | ↗ |
| Aug 18on TipRanks 05:20 | ELVNIWMEnliven Therapeutics · $2.9B | Initiated | Buy | $78.00 | +109.0% | +1.6%next day −1.3% · 5 days +1.8% | ↗ |
| Aug 14on TipRanks Aug 17 04:55 | MGNXIWMMacroGenics · $211M | Reiterated | Buy | $6.00 | +84.6% | +3.6%next day −3.3% · 5 days −1.5% | ↗ |
| Aug 12on TipRanks 05:15 | CCCCIWMC4 Therapeutics · $321M | Reiterated | Buy | $7.00 | +153.2% | +0.5%next day +3.9% · 5 days +8.4% | ↗ |
| Aug 7on TipRanks 04:19 | CTMXIWMCytomX Therapeutics · $486M | Reiterated | Buy | $16.00 | +601.8% | +2.1%next day −0.5% · 5 days −3.3% | ↗ |
| Aug 7on TipRanks 04:19 | JANXIWMJanux Therapeutics Inc · $1.1B | Reiterated | Sell | $14.00 | −15.2% | −2.2%next day +3.6% · 5 days +1.3% | ↗ |
| Aug 7on TipRanks 04:19 | CRVSIWMCorvus Pharmaceuticals · $789M | Reiterated | Buy | $28.00 | +194.1% | −0.2%next day −1.3% · 5 days +6.6% | ↗ |
| Aug 7on TipRanks 04:16 | RLAYIWMRelay Therapeutics · $3.8B | Reiterated | Buy | $27.00 → $30.00+11.1% | +84.3% | −0.5%next day +0.9% · 5 days +0.1% | ↗ |
| Aug 6on TipRanks 04:16 | EXELExelixis · $14.8B | Reiterated | Hold | $49.00 | −21.3% | −7.8%next day +3.0% · 5 days −4.3% | ↗ |
| Aug 6on TipRanks 04:16 | VIRIWMVir Biotechnology · $1.8B | Reiterated | Buy | $30.00 | +201.2% | −3.6%next day 0.0% · 5 days +1.5% | ↗ |
| Aug 5on TipRanks 04:13 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | $37.00 | +186.8% | +4.6%next day −0.6% · 5 days −1.0% | ↗ |
| Aug 5on TipRanks 04:13 | ARVNIWMArvinas Holding Company · $468M | Reiterated | Buy | $20.00 | +186.9% | −6.5%next day +3.5% · 5 days +5.2% | ↗ |
| Jul 28on TipRanks Jul 29 04:37 | INCYSPYIncyte · $23.0B | Reiterated | Buy | $134 → $139+3.7% | +22.9% | +9.1%next day −0.6% · 5 days −11.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗